683 related articles for article (PubMed ID: 33586620)
1. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
Ezaj MMA; Junaid M; Akter Y; Nahrin A; Siddika A; Afrose SS; Nayeem SMA; Haque MS; Moni MA; Hosen SMZ
J Biomol Struct Dyn; 2022 Sep; 40(14):6477-6502. PubMed ID: 33586620
[TBL] [Abstract][Full Text] [Related]
2. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
[TBL] [Abstract][Full Text] [Related]
3. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
Jyotisha ; Singh S; Qureshi IA
J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
[TBL] [Abstract][Full Text] [Related]
4. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
[TBL] [Abstract][Full Text] [Related]
5. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M
Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041
[TBL] [Abstract][Full Text] [Related]
6. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Akhtar N; Joshi A; Singh B; Kaushik V
Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
[TBL] [Abstract][Full Text] [Related]
7. A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.
Kibria KMK; Faruque MO; Islam MSB; Ullah H; Mahmud S; Miah M; Saleh AA
Appl Microbiol Biotechnol; 2022 Jun; 106(11):4091-4114. PubMed ID: 35612630
[TBL] [Abstract][Full Text] [Related]
8. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach.
Ahammad I; Lira SS
Int J Biol Macromol; 2020 Nov; 162():820-837. PubMed ID: 32599237
[TBL] [Abstract][Full Text] [Related]
9. Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2.
Mishra SK; Priya P; Rai GP; Haque R; Shanker A
Comput Biol Med; 2023 Sep; 163():107233. PubMed ID: 37422941
[TBL] [Abstract][Full Text] [Related]
10. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide.
Srivastava S; Verma S; Kamthania M; Agarwal D; Saxena AK; Kolbe M; Singh S; Kotnis A; Rathi B; Nayar SA; Shin HJ; Vashisht K; Pandey KC
J Biomol Struct Dyn; 2022 Mar; 40(5):2369-2388. PubMed ID: 33155524
[TBL] [Abstract][Full Text] [Related]
11. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein.
Sirohi PR; Gupta J; Somvanshi P; Prajapati VK; Grover A
J Biomol Struct Dyn; 2022 May; 40(8):3347-3358. PubMed ID: 33246394
[TBL] [Abstract][Full Text] [Related]
12. Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants.
Ezzemani W; Kettani A; Sappati S; Kondaka K; El Ossmani H; Tsukiyama-Kohara K; Altawalah H; Saile R; Kohara M; Benjelloun S; Ezzikouri S
J Biomol Struct Dyn; 2023 Jul; 41(11):4917-4938. PubMed ID: 35549819
[TBL] [Abstract][Full Text] [Related]
13. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.
Samad A; Ahammad F; Nain Z; Alam R; Imon RR; Hasan M; Rahman MS
J Biomol Struct Dyn; 2022 Jan; 40(1):14-30. PubMed ID: 32677533
[TBL] [Abstract][Full Text] [Related]
14. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
15. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
[TBL] [Abstract][Full Text] [Related]
16. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
[TBL] [Abstract][Full Text] [Related]
17.
Devi A; Chaitanya NSN
J Biomol Struct Dyn; 2021 Nov; 39(18):6903-6917. PubMed ID: 32772892
[TBL] [Abstract][Full Text] [Related]
18. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
19. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches.
Marriam S; Afghan MS; Nadeem M; Sajid M; Ahsan M; Basit A; Wajid M; Sabri S; Sajid M; Zafar I; Rashid S; Sehgal SA; Alkhalifah DHM; Hozzein WN; Chen KT; Sharma R
Front Cell Infect Microbiol; 2023; 13():1134802. PubMed ID: 37293206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
